Integral Ad Science Holding Corp. (NASDAQ:IAS) Given Consensus Recommendation of "Moderate Buy" by Analysts

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $13.55.

Several equities analysts recently commented on IAS shares. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Robert W. Baird restated a "neutral" rating and set a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a research report on Friday, March 28th. Stifel Nicolaus reduced their target price on Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Scotiabank started coverage on Integral Ad Science in a research report on Friday, February 28th. They set a "sector perform" rating and a $12.00 target price for the company. Finally, Benchmark restated a "hold" rating on shares of Integral Ad Science in a research report on Friday, February 28th.

Integral Ad Science Stock Performance

Shares of NASDAQ IAS traded up $0.02 during mid-day trading on Friday, hitting $8.16. The company had a trading volume of 1,151,736 shares, compared to its average volume of 1,009,183. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of 40.80, a P/E/G ratio of 1.06 and a beta of 1.55. Integral Ad Science has a 1 year low of $6.26 and a 1 year high of $13.62. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock's 50-day moving average price is $7.45 and its 200-day moving average price is $9.32.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.02. The company had revenue of $134.07 million during the quarter, compared to analysts' expectations of $129.20 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. On average, sell-side analysts forecast that Integral Ad Science will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,547 shares of the business's stock in a transaction dated Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the completion of the sale, the chief executive officer now owns 341,271 shares of the company's stock, valued at approximately $2,337,706.35. The trade was a 2.44% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In the last three months, insiders sold 86,222 shares of company stock worth $636,252. 2.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Integral Ad Science

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC bought a new stake in shares of Integral Ad Science in the 1st quarter valued at about $1,986,000. Caxton Associates LLP bought a new stake in shares of Integral Ad Science in the 1st quarter valued at about $282,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Integral Ad Science by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,326 shares of the company's stock valued at $349,000 after purchasing an additional 1,807 shares during the last quarter. Invenomic Capital Management LP raised its position in Integral Ad Science by 84.3% during the 1st quarter. Invenomic Capital Management LP now owns 1,649,983 shares of the company's stock valued at $13,299,000 after purchasing an additional 754,922 shares during the last quarter. Finally, Circumference Group LLC raised its position in Integral Ad Science by 10.5% during the 1st quarter. Circumference Group LLC now owns 210,000 shares of the company's stock valued at $1,693,000 after purchasing an additional 20,000 shares during the last quarter. Institutional investors own 95.78% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.